AKT1 and cancer: Among these, 172 pathways were significantly different (P < 0.05), including PI3K-Akt signaling pathway, proteoglycans in cancer, human cytomegalovirus infection, mitogen-activated protein kinase (MAPK) signaling pathway, as well as lipid and atherosclerosis, among others (Fig 3B).